Your browser doesn't support javascript.
loading
The HER2-binding affibody molecule (Z(HER2∶342))2 increases radiosensitivity in SKBR-3 cells.
Ekerljung, Lina; Lennartsson, Johan; Gedda, Lars.
Afiliação
  • Ekerljung L; Department of Radiology, Oncology and Radiation Sciences, Division of Biomedical Radiation Sciences, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
PLoS One ; 7(11): e49579, 2012.
Article em En | MEDLINE | ID: mdl-23166716
ABSTRACT
We have previously shown that the HER2-specific affibody molecule (Z(HER2∶342))2 inhibits proliferation of SKBR-3 cells. Here, we continue to investigate its biological effects in vitro by studying receptor dimerization and clonogenic survival following irradiation. We found that (Z(HER2∶342))2 sensitizes the HER2-overexpressing cell line SKBR-3 to ionizing radiation. The survival after exposure to (Z(HER2∶342))2 and 8 Gy (S(8Gy) 0.006) was decreased by a factor four compared to the untreated (S(8Gy) 0.023). The low HER2-expressing cell line MCF-7 was more radiosensitive than SKBR-3 but did not respond to (Z(HER2∶342))2. Treatment by (Z(HER2∶342))2 strongly increased the levels of dimerized and phosphorylated HER2 even after 5 minutes of stimulation. The monomeric Z(HER2∶342) does not seem to be able to induce receptor phosphorylation and dimerization or sensitize cells to irradiation.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tolerância a Radiação / Proteínas Recombinantes de Fusão / Receptor ErbB-2 Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2012 Tipo de documento: Article País de afiliação: Suécia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tolerância a Radiação / Proteínas Recombinantes de Fusão / Receptor ErbB-2 Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2012 Tipo de documento: Article País de afiliação: Suécia